Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Post by UberWealthon Jul 28, 2017 9:50am
136 Views
Post# 26520912

COT Share Questions

COT Share QuestionsTax loss season is coming up - does anyone have a gain on COT shares? Private Placement is coming up - is the company in a strong position?  Market Cap is now miniscule - does that attract more or less interest?  Volume has dried up - can you get in or out?  In addition, management has hired 2 PR firms - one in the U.S. Is there any U.S. buying?   Those firms were hired months ago but have been quiet.  What does that mean?  Why pay for firms to do nothing?  Management has gone through enormous changes.  Founder is gone.  High paid CEO has come in.  Stock at lows.  This company has changed. Share price has changed too.  Who is answering these questions?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities